Phase II/III trial of UB-612 vaccine
Latest Information Update: 17 Sep 2020
At a glance
- Drugs UB 612 (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Sponsors United Biomedical
- 17 Sep 2020 New trial record
- 23 Aug 2020 According to United Biomedical, Inc. (UBI) media release, the company has proposed subsidies to the US Department of Defense and the Coalition for Epidemic Preparedness Innovations (CEPI) for conducting human clinical trials in the United States. The application is expected to start this trial in Taiwan by the end of this year based on the results of Taiwan's Phase I dose-escalation trial.